Published December 20, 2020
| Version v1
Journal article
Open
SHOULD WE EXPECT AN INCREASE IN CORPORATE ESPIONAGE IN THE PHARMACEUTICAL INDUSTRY OF TOMORROW?
Creators
Description
Corporate espionage is a process of obtaining classified information from business competitors for economic reasons and gaining an advantage over the competition. This paper is presenting an analysis of industry growth, investments in R&D and the total value of the investment estimating the possible existence of trends and activities of corporate espionage in the drug development industry. Some authors analyze the cost-effectiveness of corporate espionage compared to investing in R&D, which if shows efficient - might be determining factor in broadening prohibited activities. The results of the analysis show that growing of corporate espionage might be expected in the future due to the growing impact of these industries on society.
Files
REVIZOR 91-92 2020 repozitorijum-39-49(1).pdf
Files
(470.2 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:fccd800750fdec6b85405ffdc11f965f
|
470.2 kB | Preview Download |
Additional details
References
- Jelisavac Trošić Sanja, Todić Dragoljub, Stamenović Milorad. Svetska trgovinska organizacija – životna sredina i sistem zdravstvene zaštite. Institut za međunarodnu politiku i privredu: Beograd; 2018
- Cuzovic Sreten, Cuzovic Djordje, Stamenovic Milorad. Globalizacija –Savremeni aspekti ekonmije, trgovine i zdravstva. Ekonomski Fakultet Niš: Niš; 2019
- Stamenović Milorad, Gulan Branislav, Dragaš Branko. Srbija danas — Savremeni aspekti neoliberalizma, ekonomije, demografije, zdravstva, bezbedosti i tranzicije. Prometej: Novi Sad; 2017
- Prvulovic, V. Ekonomska diplomatija/Economic Diplomacy. Megatrend Univerzitet. 2002. Belgrade
- Stamenovic Milorad, Dobraca Amra. Benefits of Outsourcing Strategy and IT Technology in Clinical Trials. Acta Inform Med. 2017;25(3):203–207
- DiMasi, Joseph A., et al. "Innovation in the Pharmaceutical Industry: New Estimates of R&D Costs." Journal of Health Economics, 2016.vol. 47
- Owoeye, O.A. Data Exclusivity and Public Health under the TRIPS Agreement. Journal of Law, Information and Science. 2014-2015. Vol 23(2)
- Evans GE. Strategic Patent Licensing for Public Research Organizations: Deploying Restriction and Reservation Clauses to Promote Medical R&D in Developing Countries. American Journal of Law and Medicine 2008